ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.720,01
-1,47%
S&P 500
5.702,55
-0,19%
Dow Jones
42.063,36
0,09%
Euro vs US Dollar
1,11705
-0,04%
Bitcoin
63.154,76
-0,08%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Axogen Inc (AXGN)

  7. Axogen Inc (AXGN) News

AXGN

Axogen (AXGN)

Axogen Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:AXGN
DatumZeitQuelleÜberschriftSymbolFirma
17/09/202422h14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
13/09/202422h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
10/09/202422h00Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:AXGNAxogen Inc
06/09/202413h09Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
06/09/202413h00GlobeNewswire Inc.Axogen Completes Submission of Biologics License Application to U.S. Food and Drug Administration for Avance Nerve Graft®NASDAQ:AXGNAxogen Inc
05/09/202422h33Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
05/09/202403h13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
05/09/202403h11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
05/09/202402h58Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
05/09/202402h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
05/09/202401h52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
04/09/202423h18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
03/09/202413h00GlobeNewswire Inc.Axogen Reports Inducement Grant to New Employee Under NASDAQ Listing Rule 5635(C)(4)NASDAQ:AXGNAxogen Inc
21/08/202422h31Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
13/08/202423h00Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
13/08/202422h18GlobeNewswire Inc.CytoSorbents Appoints Peter J. Mariani Chief Financial OfficerNASDAQ:AXGNAxogen Inc
12/08/202416h59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AXGNAxogen Inc
09/08/202422h36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AXGNAxogen Inc
09/08/202422h20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
09/08/202422h15Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
09/08/202422h05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
08/08/202422h10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AXGNAxogen Inc
08/08/202413h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AXGNAxogen Inc
08/08/202413h05GlobeNewswire Inc.Axogen, Inc. Announces New Leadership AppointmentsNASDAQ:AXGNAxogen Inc
08/08/202413h00GlobeNewswire Inc.Axogen, Inc. Reports Second Quarter 2024 Financial ResultsNASDAQ:AXGNAxogen Inc
23/07/202413h00GlobeNewswire Inc.Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024NASDAQ:AXGNAxogen Inc
01/07/202413h00GlobeNewswire Inc.Company Reports Inducement Grants to Non-Executive New Employee Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:AXGNAxogen Inc
24/06/202413h00GlobeNewswire Inc.Axogen, Inc Announces Full Launch of Avive+ Soft Tissue Matrix™NASDAQ:AXGNAxogen Inc
11/06/202400h24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
11/06/202400h22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AXGNAxogen Inc
 Showing the most relevant articles for your search:NASDAQ:AXGN

Kürzlich von Ihnen besucht

AMEX
SPY
SPDR S&P 500
TG
BAS
BASF
NYSE
MRK
Merck
CCOM
SILVER
SILVER
CCOM
US500
US 500
DBI
SDXP
SDAX
AMEX
XLV
Health Care Select Sector
TG
ALV
Allianz
DBI
MDAX
MDAX
USOTC
RHHBY
Roche (QX)
NYSE
MCD
McDonalds
TG
DBK
Deutsche Bank
NASDAQ
TSLA
Tesla
NASDAQ
GOOGL
Alphabet
FX
EURUSD
Euro vs US Dollar
USOTC
ADDYY
Adidas (QX)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten